Literature DB >> 21064243

Therapy: Bisphosphonate users: cancer risk.

Emma Leah.   

Abstract

Entities:  

Year:  2010        PMID： 21064243     DOI： 10.1038/nrrheum.2010.167

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  2 in total

1.  Exposure to oral bisphosphonates and risk of esophageal cancer.

Authors:  Chris R Cardwell; Christian C Abnet; Marie M Cantwell; Liam J Murray
Journal:  JAMA       Date:  2010-08-11       Impact factor: 56.272

2.  Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.

Authors:  Jane Green; Gabriela Czanner; Gillian Reeves; Joanna Watson; Lesley Wise; Valerie Beral
Journal:  BMJ       Date:  2010-09-01
  2 in total
  1 in total

1.  Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances.

Authors:  Ehud Segal; Huaizhong Pan; Liat Benayoun; Pavla Kopečková; Yuval Shaked; Jindřich Kopeček; Ronit Satchi-Fainaro
Journal:  Biomaterials       Date:  2011-03-22       Impact factor: 12.479
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.